Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has been granted patent for its drug candidate AC01 as an inotropic agent in the EU. AnaCardio ...
Hutter, Jr., M.D., M.A.C.C. When patients present with possible HF, initial evaluation requires a complete history and physical exam, including asking about past drug and alcohol use as well as ...
Initiation or switching β blockers is not recommended in patients experiencing a severe decompensation of HF (e.g., requiring intravenous positive inotropic agents, vasodilators, or mechanical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback